Adage Capital Partners’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-690,000
| Closed | -$13.4M | – | 1000 |
|
|
2022
Q4 | $13.4M | Buy |
690,000
+150,000
| +28% | +$2.9M | 0.03% | 559 |
|
|
2022
Q3 | $18.5M | Buy |
540,000
+182,763
| +51% | +$6.28M | 0.05% | 429 |
|
|
2022
Q2 | $5.46M | Hold |
357,237
| – | – | 0.01% | 789 |
|
|
2022
Q1 | $8.15M | Sell |
357,237
-10,000
| -3% | -$228K | 0.02% | 747 |
|
|
2021
Q4 | $13.5M | Sell |
367,237
-102,763
| -22% | -$3.79M | 0.02% | 609 |
|
|
2021
Q3 | $22.1M | Buy |
470,000
+18,320
| +4% | +$861K | 0.04% | 415 |
|
|
2021
Q2 | $27.2M | Buy |
+451,680
| New | +$27.2M | 0.05% | 365 |
|